Thermo Fisher Scientific Other Non-Current Assets increased by 17.0% to $5.87B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 30.7%, from $4.49B to $5.87B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Assets shows an upward trend with a 136.1% CAGR.
Significant changes may indicate shifts in long-term tax positions, restricted cash, or non-core strategic investments.
A catch-all category for long-term economic resources that do not fit into primary classifications like PPE or Goodwill,...
Varies widely by firm; usually represents a small percentage of total assets unless specific long-term prepayments or tax assets exist.
other_non_current_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.58B | $2.99B | $251.00M | $4.42B | $4.31B | $4.31B | $435.00M | $3.98B | $4.11B | $4.12B | $329.00M | $4.24B | $4.38B | $4.18B | $4.49B | $4.52B | $4.62B | $5.02B | $5.87B |
| QoQ Change | — | +15.8% | -91.6% | >999% | -2.7% | +0.0% | -89.9% | +815.6% | +3.1% | +0.4% | -92.0% | >999% | +3.2% | -4.5% | +7.5% | +0.5% | +2.2% | +8.8% | +17.0% |
| YoY Change | — | — | — | — | +66.6% | +44.0% | +73.3% | -10.0% | -4.6% | -4.3% | -24.4% | +6.5% | +6.5% | +1.4% | >999% | +6.5% | +5.4% | +20.1% | +30.7% |
We use cookies for analytics. See our Privacy and Cookie Policy.